课题基金 / 基金详情

Biological characterization of bradykinin receptor involved in functional control of airway

Biological characterization of bradykinin receptor involved in functional control of airway
参与气道功能控制的缓激肽受体的生物学特征
批准号:
12670094
负责人:
HAYASHI Izumi
金额:
$1.15万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

HAYASHI Izumi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Bradykinin is known to be a potent bronchoconstrictor in vivo and to cause contraction of isolated trachea. BK receptor involved in airway microvascular leak and bronchoconstriction in guinea-pig was classified as a B_2 receptor. A prominent difference of biological activity between a nonpeptide bradykinin B_2 receptor agonist FR190997 and BK was found in airway responses. FR190997 showed almost no increase in airway opening pressure (Pao) after the intravenous injection in guinea-pig, although its hypotensive response was observed. This failure to cause bronchoconstriction could be partly explained by the following results from in vitro experiments. In isolated trachea ring strips and lung parenchymal Sections, FR190997 displayed a very weak contractile activity, suggesting less bronchoconstriction in vivo. Furthermore, it is not likely that the lack of effect observed with FR190997 is due to the different animal species used, since a significant contractions of those tissue preparations were not observed in both rat and guinea-pig, and less increase in Pao at a dose of 30 nmol kg^<-1> of FR190997 was also seen even in rat species. The B_1 receptor is not seemed to be involved, based on the fact that desArg^9-bradykinin did not exhibited and increase in Pao and the B_1 receptor antagonist, desArg^9[Leu^8]-bradykinin did not significantly antagonize the increase induced by bradykinin. Thus, it could be concluded that trachea or pulmonary tissue in airway may contain a novel BK receptor other than B_1 and B_2, which may be involved in bradykinin-induced bronchoconstriction. Further studies for the elucidation will be required to identify a cDNA encoding a novel BK receptor in airway by molecular cloning. Assuming that both FR190997 and FR173657 specifically bind to the B_2 receptor, another mechanism or conformational state for the ligand to activate BK receptor, which will be specific in those tissues, would be also considerable.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Hayashi I, Ishihara K, et al.: "Proinflammatory characteristics of a nonpeptide bradykinin mimic, FR190997,in vivo"British Journal of Pharmacology. 131. 820-826 (2000)
Hayashi I、Ishihara K 等人:“非肽缓激肽模拟物 FR190997 的体内促炎特性”英国药理学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
IZUMI HAYASHI: "In vivo transfer of antisense oligonucleotide againsturinary kininase blurts deoxycorticosterone acetate-salt hypertension in rats"British Journal of Pharmacology. 131・4. 820-826 (2000)
IZUMI HAYASHI:“针对尿激肽酶的反义寡核苷酸的体内转移可导致大鼠脱氧皮质酮醋酸盐高血压”《英国药理学杂志》131·4(2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ito H, Hayashi I, Izumi T, Majima M: "Bradykinin inhibits development of myocardial infarction through B(2) receptor signaling by increment of regional blood flow around the ischaemic lesions in rats"Br J Pharmacol. 138(1). 225-233 (2003)
Ito H、Hayashi I、Izumi T、Majima M:“缓激肽通过 B(2) 受体信号传导通过增加大鼠缺血性病变周围的局部血流量来抑制心肌梗塞的发展”Br J Pharmacol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hayashi I, Amano H, et al.: "Suppressed angiogenesis in kininogen-deficiencies"Laboratory Investigation. 82. 871-880 (2002)
Hayashi I、Amano H 等人:“激肽原缺陷中抑制血管生成”实验室研究。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
36
    Primary approach for therapy of fibrosis by manipulating angiogenesis induced by biologically active autocoids
    • 批准号:
      19590072
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.08万
    • 财政年份:
      2007
    • 负责人:
      HAYASHI Izumi
    • 依托单位:
    Cell therapy by manipulation of biological function of prostaglandin as self-defense factor
    国内基金
    海外基金
    盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
    • 批准号:
      82372202
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      侯旭敏
    • 依托单位:
    GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
    • 批准号:
      82371652
    • 项目类别:
      面上项目
    • 资助金额:
      45.00万元
    • 批准年份:
      2023
    • 负责人:
      刘开江
    • 依托单位:
    多囊卵巢综合征中甲酰肽受体2调控小胶质细胞代谢重编程导致GnRH神经元过度激活及HPO轴异常的病理机制研究
    • 批准号:
      82370797
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      陶弢
    • 依托单位:
    G蛋白偶联受体GPR110调控Lp-PLA2抑制非酒精性脂肪性肝炎的作用及机制研究
    • 批准号:
      82370865
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      黄哲
    • 依托单位: